Ena Respiratory researches and develops solutions to transform the treatment and prevention of respiratory infections. Founded by Christophe Demaison in 2014, Ena Respiratory is backed by investors that include Brandon Capital Partners, CSL, Hostplus, Uniseed Ventures, and AustralianSuper and is headquartered in Melbourne.